If you are someone who thinks investments should generate regular income, it is important to watch out for dividend stocks.

Johnson & Johnson JNJ reported 2.4% sales growth (2.3% in innovative medicine, 2.5% in medtech) and 2.2% adjusted EPS growth in the first quarter. Management raised reported sales growth guidance ...

"Johnson has all the makings of a lockdown cornerback at the next level and would instantly bolster Las Vegas' defense on the outside. And, along with Jakorian Bennett, the Raiders might not have ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE ... long benefited investors by delivering consistent and solid returns. During periods of economic uncertainty ...

Why it matters: Investors were concerned about how severely the headwinds from Stelara biosimilars and the Medicare Part D redesign would hit Johnson & Johnson's financials, as well as the ...

Sen. Ron Johnson (R-Wis.) suggested in an interview released Monday that Congress could hold additional hearings on the Sept. 11, 2001, terrorist attacks and indicated he’s been listening to ...

Johnson Controls International plc, together with its subsidiaries, engages in engineering, manufacturing, commissioning, and retrofitting building products and systems in the United States ...

Johnson & Johnson announced compelling results ... was 18.19%, indicating solid long-term growth. In the last year, JNJ surpassed the US Pharmaceuticals industry, which saw an 11.5% decline ...

Johnson & Johnson MedTech (NYSE: JNJ) + announced today that investigators completed the first cases with its Ottava surgical robot. The cases, performed by Dr. Erik Wilson, mark the first ...

Michael Johnson, 54, of Beaufort, died Saturday, April 12, 2025, at his home. A memorial service to honor Michael’s life will be held at 2 p.m., Sunday, April 27 th, at Munden Funeral Home.